S. Arebee, A. 2025. CRISPR Gene-Editing Therapies for Sickle Cell Disease and Beta- Thalassemia: Clinical Outcomes, Risks and Safety Profiles. A Systematic Review. Libyan Journal of Medical and Applied Sciences. 3, 4 (Dec. 2025), 102–108. DOI:https://doi.org/10.64943/ljmas.v3i4.254.